Patent: 9,944,711
✉ Email this page to a colleague
Summary for Patent: 9,944,711
Title: | Antibodies against human CD38 |
Abstract: | Isolated monoclonal antibodies which bind to human CD38 and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies. |
Inventor(s): | De Weers; Michel (Houten, NL), Walseth; Tim (Roseville, MN), Van De Winkel; Jan (Zeist, NL), Vink; Tom (Alphen aan den Rijn, NL), Parren; Paul (Odijk, NL) |
Assignee: | GENMAB A/S (Copenhagen V, DK) |
Application Number: | 14/990,869 |
Patent Claims: | see list of patent claims |
Details for Patent 9,944,711
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 02/20/1991 | ⤷ Try a Trial | 2030-06-09 |
Amgen, Inc. | NEUPOGEN | filgrastim | Injection | 103353 | 06/28/2000 | ⤷ Try a Trial | 2030-06-09 |
Partner Therapeutics, Inc. | LEUKINE | sargramostim | For Injection | 103362 | 03/05/1991 | ⤷ Try a Trial | 2030-06-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |